Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.

@article{Buster2008PeginterferonFT,
  title={Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.},
  author={Erik H.C.J. Buster and Solko W. Schalm and Harry L. A. Janssen},
  journal={Best practice & research. Clinical gastroenterology},
  year={2008},
  volume={22 6},
  pages={
          1093-108
        }
}

• Erik H.C.J. Buster, Solko W. Schalm, Harry L. A. Janssen
• Published in
  Best practice & research…
  2008
• DOI:10.1016/j.bpg.2008.11.007

The practising clinician is currently faced with a number of effective treatment options for chronic hepatitis B, including two formulations of interferon (standard IFN and pegylated IFN) and five nucleos(t)ide analogues (lamivudine, adefovir, entecavir, telbivudine and tenofovir). Treatment strategies can be divided into those aiming for sustained response after discontinuation of therapy and those that need to be maintained by prolonged antiviral therapy. Sustained response is particularly… CONTINUE READING

View on PubMed

Alternate Sources

Save to Library

Create Alert

Cite